Article Information
History
- August 6, 2021.
Article Versions
- You are currently viewing Version 1 of this article (August 6, 2021 - 01:56).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nicholas D. Peterson1,#,
- Janneke D. Icso2,#,
- J. Elizabeth Salisbury1,
- Tomás Rodríguez3,
- Paul R. Thompson2,* and
- Read Pukkila-Worley1,*
- 1Program in Innate Immunity, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, 01655, United States of America
- 2Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, 01655, United States of America
- 3RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01655, United States of America
- ↵*Correspondence may be addressed to Read Pukkila-Worley (Read.Pukkila-Worley{at}umassmed.edu, Read.Pukkila-Worley{at}RPWlab) or Paul Thompson (Paul.Thompson{at}umassmed.edu, Paul.Thompson{at}pthompsn1018)
↵# These authors contributed equally to this work